Abstract
To evaluate the potential of the expression of the sodium/iodide symporter (NIS) as a means of targeting radioiodine to tumor cells, we have employed plasmid-mediated transfection of the NIS gene into a range of mammalian cell hosts. We observed perchlorate-inhibitable iodide uptake up to 41-fold over control in all NIS-transfected cells. We assessed the effect of NIS expression followed by exposure to on the clonogenic survival of UVW glioma cells. After exposure of two-dimensional monolayer cultures of UVW–NIS cells to at a radioactive concentration of 4 MBq/mL, clonogenic survival was reduced to 21%. Similar treatment of UVW–NIS cells in three-dimensional spheroid cultures resulted in a reduction of clonogenic survival to 2.5%. This increase in sensitivity to exposure is likely to be due to a radiological bystander effect. These results are very encouraging for the development of a novel cytotoxic gene-therapy strategy in which a radiological bystander effect plays a significant role in tumor cell sterilization. Cancer Gene Therapy (2000) 7, 1529–1536.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carlin, S., Cunningham, S., Boyd, M. et al. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional models. Cancer Gene Ther 7, 1529–1536 (2000). https://doi.org/10.1038/sj.cgt.7700264
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700264
Keywords
This article is cited by
-
Viral dose, radioiodide uptake, and delayed efflux in adenovirus-mediated NIS radiovirotherapy correlates with treatment efficacy
Gene Therapy (2013)
-
Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter
Cancer Gene Therapy (2011)
-
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging (2008)
-
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone
Breast Cancer Research and Treatment (2008)
-
Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo
European Journal of Nuclear Medicine and Molecular Imaging (2007)